Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis

INTRODUCTION: Kallistatin levels in the circulation are reduced in patients with sepsis and liver disease. Transgenic mice expressing kallistatin are resistant to lipopolysaccharide (LPS)-induced mortality. Here, we investigated the effect of kallistatin on survival and organ damage in mouse models...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Crit Care
Autors principals: Li, Pengfei, Guo, Youming, Bledsoe, Grant, Yang, Zhi-Rong, Fan, Hongkuan, Chao, Lee, Chao, Julie
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4445990/
https://ncbi.nlm.nih.gov/pubmed/25930108
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0919-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars